Arkolith/Insider Trading/FBIO/Form 4

Rosenwald Lindsay A MD

President, CEO & Chairman, Director, 10% OwnerFortress Biotech, Inc. (FBIO) · full profile →Form 4 · filed Aug 21, 2023
Net Buying
Open-Market Buys
$211K
Open-Market Sells
$0
Net Open-Market Flow
$211K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 18, 2023Buy(P)10K$9.34$93K113K
Aug 17, 2023Buy(P)10K$11.75$118K103K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-23-093700) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML